Advertisement

Topics

SanBio Co., Ltd. Company Profile

11:32 EDT 18th June 2018 | BioPortfolio

SanBio (TOKYO:4592) is a leading regenerative medical products company headquartered in Tokyo and Mountain View, California, with cell-based products in various stages of research, development and clinical trials. The company has completed enrollment for and is conducting a Phase 2b clinical trial for its proprietary regenerative medical product SB623 for the treatment of chronic motor impairments resulting from stroke with its joint development partner, Sunovion Pharmaceuticals Inc., an indirect, wholly-owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd., in the United States and Canada. It is also conducting a Phase 2 clinical trial to evaluate the safety and efficacy of SB623 to treat impairments resulting from traumatic brain injury. Enrollment for that trial is close to complete. More information about SanBio, Inc., is available at http://sanbio.com.


News Articles [6 Associated News Articles listed on BioPortfolio]

SanBio's US-based Phase 1/2a Clinical Trial of SB623 for the Treatment of Chronic Motor Deficit from Ischemic Stroke Was Addressed at an Event Held by California Institute for Regenerative Medicine (CIRM)

The SanBio Group (SanBio Co., Ltd. and subsidiary SanBio, Inc.), a scientific leader in regenerative medicine for neurological disorders, hereby announces that the US-based...

SanBio Primary Researcher Receives 2017 Smithsonian American Ingenuity Award

Dr. Gary Steinberg recognized for promising research with SanBio’s stem cell therapy SanBio, Inc., a leader in regenerative cell therapies for neurological disorders,...

Research Paper Co-authored by Dr. Damien Bates, Chief Medical Officer and Head of Medical Research at SanBio Group, Published in Stroke

The SanBio Group (SanBio Co., Ltd. and subsidiary SanBio, Inc.), a scientific leader in regenerative medicine for neurological disorders, hereby announces that

SanBio Signs Contract Mfg. Agreement with Hitachi Chemical

Hitachi will manufacture of regenerative medicine product SB623

SanBio: Update on Development Progress of Regenerative Cell Medicine SB623

The SanBio Group (SanBio Co., Ltd. and subsidiary SanBio Inc.) (TOKYO:4592) has updated part of its March 13, 2018 release “Update on Development Progress of Regenerative Cell M...

SanBio Reaches Agreement on Manufacture of Regenerative Medicine Product SB623 with Hitachi Chemical

SanBio Group and Hitachi Chemical Co., Ltd. (Hitachi Chemical) jointly announced today that, through an agreement with Hitachi Chemical Advanced Therapeu

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [5 Associated Companies listed on BioPortfolio]

SanBio, Inc.

SanBio is a regenerative medicine company with cell based products in various stages of research, development and clinical trials. Its proprietary cell based product, SB623, is be...

SanBio Co., Ltd.

SanBio (TOKYO:4592) is a leading regenerative medical products company headquartered in Tokyo and Mountain View, California, with cell-based products in various stages of research...

SANBIO BV

Through regular contact with our customers in the Benelux and Germany, Sanbio has been able to offer a wide range of biotechnology and research products in the field of immunology, pathology, molecula...

SanBio Inc.

SanBio, Co. Ltd.

More Information about "SanBio Co., Ltd." on BioPortfolio

We have published hundreds of SanBio Co., Ltd. news stories on BioPortfolio along with dozens of SanBio Co., Ltd. Clinical Trials and PubMed Articles about SanBio Co., Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of SanBio Co., Ltd. Companies in our database. You can also find out about relevant SanBio Co., Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...


Corporate Database Quicklinks



Searches Linking to this Company Record